Abiopharma

🔍 Carson Brian Jay (Executive)

Company: CLEANSPARK, INC. (CLSK)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | shares_owned_after: 47,321.00
• Acquired 100,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F7, F7
• Acquired 75,000 shares of Performance Stock Units (Derivative)
  Date: 2026-03-20 | Code: A | equity_swap_involved: false | shares_owned_after: 75,000.00 | transaction_form_type: 4 | Footnotes: F8, F8
• Holds 12,500 shares of Employee Stock Options (Right to Buy) at $2.83 per share (Derivative)
  Date: 2026-03-20 | Code: H | Expires: 2032-10-14 | shares_owned_after: 12,500.00 | Footnotes: F1
• Holds 10,000 shares of Employee Stock Options (Right to Buy) at $6.0 per share (Derivative)
  Date: 2026-03-20 | Code: H | Expires: 2033-07-06 | shares_owned_after: 10,000.00 | Footnotes: F2
• Holds 5,000 shares of Employee Stock Options (Right to Buy) at $16.15 per share (Derivative)
  Date: 2026-03-20 | Code: H | Expires: 2034-05-03 | shares_owned_after: 5,000.00 | Footnotes: F3
• Holds 280,837 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 280,837.00 | Footnotes: F4, F4
• Holds 81,875 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 81,875.00 | Footnotes: F5, F5
• Holds 131,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-20 | Code: H | shares_owned_after: 131,000.00 | Footnotes: F6, F6

Footnotes:

• F1: These Options were granted on October 14, 2022 and vest in equal monthly installments over 36 months.
• F2: These Options were granted on July 7, 2023 and vest in equal monthly installments over 36 months.
• F3: These Options were granted on May 3, 2024 and vest in equal monthly installments over 36 months.
• F4: These RSUs vest in equal annual installments over three years on September 4, 2026, September 4, 2027, and September 4, 2028.
• F5: These RSUs vest 25% on September 9, 2025; the remaining 75% vests in equal semiannual installments over three years on February 13, 2026, September 4, 2026, February 13, 2027, September 4, 2027,February 13, 2028, and September 4, 2028.
• F6: These RSUs vest in equal annual installments over three years on September 4, 2026, September 4, 2027, and September 4, 2028.
• F7: These RSUs vest in equal annual installments over three years on March 20, 2027, March 20, 2028, and March 20, 2029, subject to the Reporting Person's continued employment or service with the Issuer through each such date.
• F8: Vesting of these Long-Term Incentive Plan ("LTIP") awards is contingent on the common stock achieving a specified target market price of at least $18.80 based on a 20-trading day average during the period ending March 20, 2027, subject to the Reporting Person remaining employed by the Issuer on the vesting date of March 20, 2029. The reported LTIP awards do not include LTIP awards in respect of a maximum of 75,000 shares of common stock for which such awards will vest in accordance with their terms upon achievement of specified performance goals tied to gross power under leases to customers for data centers, with threshold performance at 600 MW gross and maximum payout at 800 MW gross, during the period ending March 20, 2027, subject to the Reporting Person remaining employed by the Issuer on the vesting date of March 20, 2029.